Research and Innovation

Conscious Research and Innovation

Ekuberg Pharma has nurtured over the years the daily dialogue with expert dermatologists and rheumatologists in order to research solutions, which answer to the real needs of dry and delicate skin.

Its orientation to conscious innovation is the consequence of its engagement also in the field of rare diseases, such as Scleroderma. In collaboration and synergy with specialists and in association with “Lega Italiana Sclerosi Sistemica”, Ekuberg Pharma wanted to focus on diseases of patients with scleroderma. The main goal is to guarantee also to these people the comfort and well-being of the skin, visible and perceived, with the consequent improvement of their quality of life and of their approach to the pathology.

Science & Nature

Ekuberg Pharma believes and implements the value of “human-friendly solutions”, starting from exclusive formulations. In fact, Research starts from the study of actives principles, which are already present in nature, combined with science innovation, in order to obtain the most benefits from the resources we have in our universe.

Thanks to its innovative formulations and to the study of the skin and its characteristics and needs, Ekuberg Pharma aims also at reducing the side effects of the main factors, which could cause alteration of the skin function, in particular the pharmacological treatments.

The efficacy, the safety and the effectiveness to satisfy the specific needs of sensitive skin have been proven by strict IN VIVO and IN VITRO TESTS, for a high tolerance, also for the most delicate skins.

All DermoACM® products have undergone dermatological test, with a patch test applied for 48 hours, and heavy metal test (Nickel, Chrome and Cobalt) on every batch.